Topical therapies for periorbital cutaneous malignancies: indications and treatment regimens.
Sullivan TJ.
Curr Opin Ophthalmol · review; journal article · DOI 10.1097/icu.0b013e328356ad55 PUBLIKATIONSREGISTRET
Gå till forskningen.
Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.
Publikationer som ChEBI hänvisar till för ingenol mebutate. Visa hela publikationsregistret
En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.
Publikationer i urvalet
16 träffarNew developments in the treatment of actinic keratosis: focus on ingenol mebutate gel.
Berman B.
Clin Cosmet Investig Dermatol · review-article; journal article · DOI 10.2147/ccid.s28905Ivacaftor, vismodegib, and ingenol mebutate.
Hussar DA, Eckel SP.
J Am Pharm Assoc (2003) · journal article · DOI 10.1331/japha.2012.12517Ingenol mebutate (Picato) for actinic keratosis.
Författaruppgift saknas
Med Lett Drugs Ther · journal articleIngenol mebutate gel for actinic keratosis.
Lebwohl M, Swanson N, Anderson LL, Melgaard A, Xu Z, Berman B.
N Engl J Med · research support, non-u.s. gov't; multicenter study; randomized controlled trial; journal article · DOI 10.1056/nejmoa1111170Ingenol mebutate: an introduction.
Fallen RS, Gooderham M.
Skin Therapy Lett · journal articleIngenol mebutate field-directed treatment of UVB-damaged skin reduces lesion formation and removes mutant p53 patches.
Cozzi SJ, Ogbourne SM, James C, Rebel HG, de Gruijl FR, Ferguson B, Gardner J, Lee TT, Larcher T, Suhrbier A.
J Invest Dermatol · research support, non-u.s. gov't; journal article · DOI 10.1038/jid.2011.418[What's new in dermato-oncology?].
Basset-Séguin N.
Ann Dermatol Venereol · review; journal article · DOI 10.1016/s0151-9638(11)70099-0Dual mechanism of action of ingenol mebutate gel for topical treatment of actinic keratoses: rapid lesion necrosis followed by lesion-specific immune response.
Rosen RH, Gupta AK, Tyring SK.
J Am Acad Dermatol · review; journal article · DOI 10.1016/j.jaad.2010.12.038Topical antineoplastic agents in the treatment of mucocutaneous diseases.
Grossberg AL, Gaspari AA.
Curr Probl Dermatol · review; journal article · DOI 10.1159/000321056An update on nonmelanoma skin cancer.
Patel RV, Frankel A, Goldenberg G.
J Clin Aesthet Dermatol · review-article; journal articleThe sap from Euphorbia peplus is effective against human nonmelanoma skin cancers.
Ramsay JR, Suhrbier A, Aylward JH, Ogbourne S, Cozzi SJ, Poulsen MG, Baumann KC, Welburn P, Redlich GL, Parsons PG.
Br J Dermatol · clinical trial, phase ii; research support, non-u.s. gov't; clinical trial, phase i; journal article · DOI 10.1111/j.1365-2133.2010.10184.xNonsurgical innovations in the treatment of nonmelanoma skin cancer.
Amini S, Viera MH, Valins W, Berman B.
J Clin Aesthet Dermatol · review-article; journal articlePEP005 (ingenol mebutate) gel for the topical treatment of superficial basal cell carcinoma: results of a randomized phase IIa trial.
Siller G, Rosen R, Freeman M, Welburn P, Katsamas J, Ogbourne SM.
Australas J Dermatol · clinical trial, phase ii; research support, non-u.s. gov't; randomized controlled trial; journal article · DOI 10.1111/j.1440-0960.2010.00626.xRandomized, double-blind, double-dummy, vehicle-controlled study of ingenol mebutate gel 0.025% and 0.05% for actinic keratosis.
Anderson L, Schmieder GJ, Werschler WP, Tschen EH, Ling MR, Stough DB, Katsamas J.
J Am Acad Dermatol · research support, non-u.s. gov't; randomized controlled trial; journal article · DOI 10.1016/j.jaad.2009.01.008PEP005 (ingenol mebutate) gel, a novel agent for the treatment of actinic keratosis: results of a randomized, double-blind, vehicle-controlled, multicentre, phase IIa study.
Siller G, Gebauer K, Welburn P, Katsamas J, Ogbourne SM.
Australas J Dermatol · clinical trial, phase ii; research support, non-u.s. gov't; multicenter study; randomized controlled trial; journal article · DOI 10.1111/j.1440-0960.2008.00497.x